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SHORT COMMUNICATION
Caprine PRNP polymorphisms N146S 
and Q222K are associated with proteolytic 
cleavage of  PrPC
Sally A. Madsen‑Bouterse1* , Paula Stewart2, Helen Williamson2, David A. Schneider1,3 and Wilfred Goldmann2 
Abstract 
Expression of the cellular prion protein  (PrPC) is crucial for the development of prion diseases. Amino acid changes 
in  PrPC or a reduced amount of  PrPC may modulate disease resistance. The relative abundance of C1, a natural 
α‑cleavage fragment of  PrPC, was previously found to be associated with a resistant PRNP genotype in sheep. Goats 
are another small ruminant where classical scrapie susceptibility is under strong genetic control. In this study, we 
assessed  PrPC in goats for the existence of similar associations between  PrPC fragments and genotype. Brain tissue 
homogenates from scrapie‑free goats with wild type PRNP or polymorphisms (I142M, H143R, N146S, or Q222K) were 
deglycosylated prior to immunoblot for assessment of the relative abundance of the C1 fragment of  PrPC. The pres‑
ence of  K222 or  S146 alleles demonstrated significantly different relative levels of C1 compared to that observed in wild 
type goats, which suggests that the genotype association with C1 is neither unique to sheep nor exclusive to the 
ovine Q171R dimorphism.
© The Author(s) 2021. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco 
mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ 
zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Expression of the cellular form of the prion protein 
 (PrPC) is essential for the pathogenesis of a group of dis-
orders called prion diseases, also known as transmissi-
ble spongiform encephalopathies (TSE). Prion diseases 
include Creutzfeldt–Jakob disease (CJD) in man, chronic 
wasting disease (CWD) in deer, bovine spongiform 
encephalopathy (BSE) in cattle and scrapie in sheep and 
goats. Prion diseases are marked by the accumulation 
of protease-resistant isoforms of the prion protein, des-
ignated  PrPSc, in the central nervous system [1]. Accu-
mulation of  PrPSc occurs by a mechanism of seeded 
conversion of  PrPC which can result in  PrPSc aggregates 
ranging from discrete fibrils to diffuse amyloid plaques 
[2].
PrPC is encoded by the PRNP gene and is most highly 
expressed in the central nervous system [3, 4]. The bio-
logical function of  PrPC is not clear, but roles in cell 
survival, circadian rhythm, myelin maintenance, and 
immunity have been suggested (reviewed by [5]).  PrPC 
from brain tissue is readily visualized by immunoblot 
using prion protein-specific antibodies. Before enzymatic 
deglycosylation,  PrPC occurs in three bands with appar-
ent molecular weights of 33–35  kDa (di-glycosylated), 
30–32  kDa (mono-glycosylated) and 25–27  kDa (un-
glycosylated), all bearing a GPI-anchor. The  PrPC bands 
detected after deglycosylation typically have apparent 
molecular weights of 26  kDa, 18  kDa and 16  kDa, rep-
resenting full-length  PrPC (209 amino acids) and two 
shorter fragments generated by proteolytic cleavage ([6] 
and reviewed in [7, 8]). Of the two shorter fragments, 
the 16  kDa band represents a 120 amino acid C-termi-
nal fragment (C1) produced by the so-called α-cleavage 
between  histidine114 and  valine115. The 18  kDa band 
represents an approximately 142 amino acid C-termi-
nal fragment (C2) produced by β-cleavage at or near 
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 glycine92. The C2 fragment tends to occur at low levels 
(relative to C1) in healthy animals and may represent a 
response to oxidative stress [8].
It is a long held view that incubation periods of prion 
diseases are correlated with the amount of  PrPC avail-
able for conversion to  PrPSc. This has been demonstrated 
in various transgenic mouse models in which incuba-
tion periods of experimentally-induced prion disease are 
inversely correlated with the expression level of mature 
full-length  PrPC [9, 10]. However, the C1 fragment does 
not convert into a protease-resistant isoform in scrapie-
challenged transgenic mice expressing only C1 [11]. 
Furthermore, co-expression of C1 with full-length  PrPC 
resulted in extended incubation periods. Likewise, cell 
lines with higher levels of C1 are relatively less permis-
sive to prion infection [12]. This raises the possibility that 
 PrPC cleavage may modulate prion diseases by reducing 
the amount of full-length  PrPC available for conversion 
or C1 fragment-mediated inhibition of full-length  PrPC 
conversion. Interestingly, a laboratory-generated  PrPC 
deletion mutant was found to undergo spontaneous con-
version to a prion of similar size as the C1 fragment [13]. 
This new type of prion was also able to infect and propa-
gate in a cell line that expressed the deletion-mutant  PrPC 
C1 fragment only. While these observations suggest that 
the C1 fragment may be susceptible to prion conversion 
in the presence of additional modifications, the C1 frag-
ment of natural  PrPC appears to be relatively resistant to 
both spontaneous and seeded prion conversion.
Polymorphisms in the PRNP gene that encode  PrPC 
protein sequence variants (allotypes) can impact prion 
disease susceptibility and incubation period (reviewed in 
[14, 15]). In sheep, the proteolytic processing of  PrPC in 
the brain depends on the PRNP genotype [16], such that 
the relative amount of the C1 fragment is increased and 
that of the C2 fragment is decreased in PRNP genotypes 
associated with resistance to classical scrapie. Similar co-
associations of  PrPC allotypes with proteolytic process-
ing and disease phenotypes remain to be investigated in 
other species. In this study, the relative amounts of  PrPC 
and C-terminal fragments present in the brain of scrapie-
free goats were compared for  PrPC allotypes known to be 
either associated with delayed incubation or reduced sus-
ceptibility risk of classical scrapie.
Methods
Study population
All animals were maintained under animal care using 
protocols approved by the Washington State Univer-
sity Institutional Animal Care and Use Committee, or 
the University of Edinburgh Animal Welfare and Ethi-
cal Review Body. In an effort to include as genetically 
diverse a population as possible, 50 goats of various 
breeds from two geographically distinct countries were 
used (ADRU/WSU n = 25 and Roslin n = 25). All goats 
were confirmed as scrapie negative or ‘not detected’ in 
the post-mortem examination of formalin-fixed lymph 
node and brain tissues by standard laboratory diagnos-
tic methods [17, 18]. PRNP genotypes were determined 
by DNA sequence analyses as previously described [19, 
20] and confirmed according to protocols described by 
Goldmann and colleagues [21, 22]. More than 50 PRNP 
gene polymorphisms have been identified in goats, many 
of which encode  PrPC allotypes [20, 23]. Polymorphisms 
that encode a serine (S) or a proline (P) at codon 240 are 
both considered to be wild type for caprine PRNP and 
are susceptible to scrapie [24, 25]. Additional polymor-
phisms appear in combination with S240P and some of 
these are associated with modulated susceptibility, incu-
bation periods, or pathology of prion diseases (reviewed 
by [14]). Of interest in the current study are goat geno-
types defined by polymorphisms that result in amino 
acid changes at codons 142 (isoleucine to methionine, 
I142M), 143 (histidine to arginine, H143R), 146 (aspara-
gine to serine, N146S), and 222 (glutamine to lysine, 
Q222K). Since the amino acid encoded by codon 240 is 
not present in mature full-length  PrPC, the relative frag-
mentation of  PrPC was determined for the available allele 
combinations where  I142H143N146Q222 is wild type.
Brain tissue preparations
All tissues were stored at −  70  °C and transported at 
−  20  °C. Each sample of brain tissue (cortex, brainstem 
and (or) cerebellum) was manually homogenised in lysis 
buffer (5% NP-40 (v/v), 12.1 mM sodium deoxycholate in 
PBS) with protease inhibitors (10 µM PMSF, 10 µM NEM 
or Complete Mini Tablets, Roche) to make a 10% (w/v) 
homogenate. The homogenate was clarified by centrifu-
gation at 400g at 4  °C for 10  min, the supernatant was 
collected, flash frozen and stored at − 20 °C until further 
analysis.
Deglycosylation
Brain homogenate (10% w/v) was denatured at 100 °C for 
10 min and incubated with 0.125U of peptide N-glycoside 
F (PNGaseF kit, New England Biolabs) at 37  °C for 2  h 
according to manufacturer’s instructions. Deglycosylated 
protein was precipitated with methanol and stored at 
−  20  °C. Before immunoblotting, protein was pelleted 
by centrifugation at 10,400g for 10 min at 4 °C. Samples 
were suspended in NuPAGE sample buffer (Invitrogen) 
supplemented with a reducing agent (Invitrogen).
SDS‑PAGE and immunoblotting
Deglycosylated protein was denatured at 70 °C for 10 min 
and separated on 12% NuPAGE Bis–Tris gels (Invitrogen) 
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or 12% Criterion gels (BioRad). Molecular markers span-
ning 10–250  kDa were used for size reference (Mag-
icMarker XP Western protein standard, Invitrogen; 
Precision Plus Protein Western C standard, Bio-Rad) and 
electrophoresis was performed in an Xcell SureLock tank 
at 150 V for 1 h using a NuPAGE™ MOPS SDS buffer kit 
for Bis–Tris gels (Invitrogen) or 20× XT MOPS running 
buffer kit (BioRad). Proteins were transferred onto poly-
vinylidene difluoride membranes (PVDF; Millipore or GE 
Healthcare) at 25 V for 1 h, after which the membranes 
were washed with TBS (50 mM Tris, 150 mM NaCl, pH 
7.5). The membranes were blocked using 1% (v/v) block-
ing solution in TBS (Western Blocking Reagent; Roche) 
for 1 h at room temperature under agitation followed by 
incubation with PrP-specific antibodies and anti-tubu-
lin (protein loading control, anti-murine α-tubulin  IgG1 
0.01 μg/mL; Fisher Scientific) diluted in 0.5% (v/v) block-
ing solution under the same conditions. Prion protein 
specific monoclonal antibodies included BC6 (0.1  μg/
mL), FH10 (0.5  μg/mL), F89/160.1.5 (3.5  μg/mL) and 
F99/97.6.1 (3.5  μg/mL) (Table  1). Antibodies BC6 and 
FH10 were obtained from the TSE Resource Centre, The 
Roslin Institute, University of Edinburgh [26]; antibodies 
F89.160.1.5 and F99/97.6.1 were prepared from hybrido-
mas maintained at the USDA Animal Disease Research 
Unit [27, 28]. Membranes were washed with TBST (0.1% 
Tween 20 in TBS) followed by 0.5% (v/v) blocking solu-
tion. The membranes were incubated in horseradish-
peroxidase-conjugated rabbit anti-mouse at 0.08  μg/mL 
(Stratech, UK) in 0.5% (v/v) blocking solution for 75 min. 
The membranes were washed in TBST and proteins were 
visualized using activated chemiluminescence (Super-
Signal West Dura Extended Duration Substrate, Thermo 
Scientific) and Lumi-Film Chemiluminescent Detection 
Film (Roche).
Data analysis
For quantitative analysis, blots were scanned and the 
net intensity of manually-selected protein bands that 
were representative of full-length  PrPC, C1 and C2 were 
measured using Adobe Photoshop and (or) ImageJ. The 
relative amount of each band was expressed as a percent-
age of the sum of all three bands per animal. The median 
percentage of C1 was calculated for each goat from all 
observations detected with a single antibody (deglyco-
sylation, immunoblot, and densitometry; the  number 
of values contributing to the  median  for each antibody 
ranged from one to six per goat). The mean percentage 
of C1 was calculated from antibody medians for each 
goat. Allotype-associated differences in mean percentage 
of C1 were assessed using beta regression (PROC GLIM-
MIX; SAS version 9.4, SAS Institute Inc., Cary, NC, USA) 
with stepdown Dunnett post-hoc testing of comparisons 
relative to wild type. Significance was attributed to effects 
with p-values < 0.05.
Results and discussion
Relative abundance of  PrPC C1 fragment in goats with wild 
type PRNP and genotypes associated with delayed scrapie 
incubation
The brain is the penultimate site of  PrPC conversion to 
 PrPSc prior to the development of clinical signs associated 
with classical scrapie. Brain from each goat was collected 
at cull and frozen until homogenization, deglycosyla-
tion, and immunoblotting. The ability to detect  PrPC by 
immunoblot can depend on factors that affect antibody 
affinity and specificity. Previous studies have demon-
strated that PRNP polymorphisms encoding amino acid 
changes can impact antibody-based prion protein detec-
tion [26, 30]. Thus, detection in this study was performed 
with several PrP-specific monoclonal antibodies (BC6, 
FH10, F89/160.1.5, or F99/97.6.1; Table 1) and detection 
of alpha-tubulin was used as a loading control (Fig. 1). All 
the PrP-specific antibodies bind epitopes that are present 
in full-length  PrPC, C1, and C2 fragments in wild type 
goats  (II142–HH143–NN146–QQ222). Most samples were 
tested with BC6, which was previously used in sheep [16]. 
The relative amount of C2 was very low in all goats and 
will not be discussed further except to note a similarly 
low amount of C2 in sheep with a PRNP genotype that 
is associated with resistance to classical scrapie [16]. For 
all goats, the relative abundance of C1 was determined in 
homogenates prepared from cortex. Brainstem and (or) 
cerebellum were also sampled in a subset of goats. The 
relative amount of C1 fragment to total  PrPC was con-
sistent across the three brain regions (Fig.  2); thus, all 
observations from a single goat were combined regard-
less of the brain region sampled. Uniformity across brain 
regions is comparable to what was observed in sheep 
[16]. In the brain of wild type goats (n = 22), the mean 
(± standard deviation) percentage of C1 relative to total 
 PrPC was 46.9 ± 9.3% (Table 2). There were no significant 
Table 1 PrP‑specific monoclonal antibodies used to detect full‑
length  PrPC, C1, and C2
a Amino acids in bold font may be altered due to single nucleotide 
polymorphisms known to occur in caprine PRNP [29]. Underlined amino acids 
are the focus of the current study
b First description of prion protein‑specific antibody
Antibody Epitopea Isotype Referencesb
BC6 144FGNDYEDRYYR154 IgG1 [26]
FH10 202TETDIKIME210 IgG2a [26]
F89/160.1.5 142IHFG145 IgG1 [28]
F99/97.6.1 220QYQRES224 IgG1 [27]
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differences between measurements based on BC6 alone 
(49.2 ± 11.9%, n = 22), FH10 alone (44.3 ± 9.2%, n = 18) 
or F99/97.6.1 alone (50.5 ± 10.2%, n = 9) (see Additional 
file 1:Table S1). Antibody F89/160.1.5 was only used for 
five of the 22 wild type samples, but the results were not 
significantly different from the other antibodies. Thus, 
the choice of antibody did not appear to influence the 
results for wild type goats.
Prion protein allotypes resulting from single PRNP 
polymorphisms had a significant effect on the relative 
amount of C1 (p = 0.002). Post-hoc testing using a step-
down Dunnett’s approach was used to evaluate which 
allotypes were significantly different from the wild type. 
Several goats included in this study had prion protein 
allotypes that have been associated with delayed incu-
bation of scrapie. Three of the goats were of the  IM142–
HH143–NN146–QQ222 allotype and had mean C1 levels of 
41.9 ± 10.4%, which was not significantly different from 
that of the wild type (Table 2). When the H143R allotype 
was considered  (II142–HR/RR143–NN146–QQ222), the 
mean C1 level in heterozygous goats  (HR143; n = 5) was 
53.8 ± 6.7% whereas homozygous goats with the alterna-
tive allotype  (RR143; n = 5) had a mean C1 of 47.2 ± 9.2%. 
These values were also not significantly different from 
that of the wild type. Thus, the relative amount of C1 in 
goats does not appear to be associated with amino acid 
changes at codons 142 and 143, which are PRNP poly-
morphisms linked to delayed incubation of classical scra-
pie in goats [25, 31].
Fig. 1 Goat  PrPC before and after deglycosylation. Representative 
immunoblots of cortex homogenate (20 µg total protein) prepared 
from goats of different genotypes before (−) and after (+) treatment 
with PNGaseF. Detection of tubulin (~ 50 kDa) was used to assess 
sample loading. In deglycosylated samples (+), full‑length  PrPC is 
visible at ~ 26 kDa and the C1 fragment at ~ 16 kDa. Detection with 
anti‑PrP antibodies BC6 (a), FH10 (b), F89/160.1.5 (c), and F99/97.6.1 
(d) demonstrates the impact of alternative alleles on  PrPC detection. 
Additional panels show reduced detection by BC6 in  RR143 goat (a), a 
longer film exposure to demonstrate the faint full‑length  PrPC bands 
in samples with an allele encoding  K222 (b), a shorter film exposure for 
 NS146 goat (c), and panel in (d) shows lack of detection by F99/97.6.1 
in  KK222 goats even after a long film exposure. WT =  II142–HH143–
NN146–QQ222; HR =  II142–HR143–NN146–QQ222; RR =  II142–RR143–NN146–
QQ222; NS =  II142–HH143–NS146–QQ222; QK =  II142–HH143–NN146–QK222; 
KK =  II142–HH143–NN146–KK222
Fig. 2 The region of the brain sampled does not significantly alter 
the relative abundance of C1 in goats. Cortex, cerebellum and (or) 
brainstem from a subset of goats were assessed by immunoblot 
using two different prion protein‑specific antibodies. Brain region 
associated differences in percentage of C1 were assessed using beta 
regression (PROC GLIMMIX; SAS version 9.4, SAS Institute Inc., Cary, 
NC, USA). There were no significant differences due to the brain 
region sampled, the antibody used for detection (e.g. F99/97.6.1 
versus FH10), or the interaction between brain region and antibody 
(p > 0.05)
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Relative abundance of  PrPC C1 fragment in goats 
with PRNP genotypes associated with reduced‑risk 
of scrapie
A polymorphism encoding an amino acid change at 
codon 146 has been associated with a reduced risk and 
putative resistance to scrapie in goats [32–35]. The allele 
encoding  S146 has been observed at a low frequency 
in meat goat breeds in Great Britain [21, 22] and some 
European Union member states [29];  S146 appears to 
be at a modestly higher frequency in meat breeds and 
some dairy breeds in the USA [20]. In this study, brain 
homogenates were available from five goats bearing the 
 II142–HH143–NS146–QQ222 genotype. The mean C1 level 
in  NS146 goats was 33.7 ± 3.2%, which was significantly 
lower than that of wild type goats (p = 0.0002 compared 
to wild type, n = 22) (Table 2 and Fig. 3a). The presumed 
epitope for antibody binding with BC6 [26] includes the 
amino acid at codon 146 (Table  1), thus, samples with 
 NS146 were also tested with additional prion protein-spe-
cific antibodies. Differences between the percentage of 
C1 with BC6 versus with the other antibodies tested were 
not significant (see Additional file  1: Table  S1). Hence, 
the observed decrease in percentage of C1 relative to that 
in wild type goats was not due to epitope-associated vari-
ation in PrP detection. Regardless of the antibody used 
for detection, there appeared to be more glycosylated 
 PrPC in brain homogenate from  NS146 goats than from 
wild type (Fig. 1, samples that did not undergo treatment 
with PNGaseF prior to immunoblotting are indicated by 
a negative sign above the lane). All  NS146 goats included 
in this study were of the Nubian breed whereas wild type 
goats were primarily Saanen or of mixed breed (mainly 
Saanen crosses), thus, the impact of genotype indepen-
dently of the breed on  PrPC glycosylation could not be 
evaluated with the available samples. Whether  PrPC gly-
cosylation has a direct impact on  PrPC proteolytic pro-
cessing to yield the C1 fragment has yet to be investigated 
but observations in mice seem to suggest a role for glyco-
sylation [36]. Although it was not the focus of the study 
by Wiseman and colleagues [36], the level of the C1 frag-
ment was higher in glycosylation-deficient mice than in 
wild type mice or gene-targeted mice with reduced  PrPC 
glycosylation. The potential role of  PrPC glycosylation on 
the reduced abundance of the C1 fragment in  NS146 goats 
is of interest and should be examined in future studies.
In recent years, the  K222 allele has been of particular 
interest in goats because of the epidemiological evidence 
that suggests relative resistance of animals carrying this 
allele, and because of experimental studies that demon-
strated a strong resistance to infection with scrapie in 
goats with this allele [22, 24, 29, 32, 33, 35, 37–40]. In 
the current study, 11 goats had at least one allele encod-
ing  K222. Goats with  II142–HH143–NN146–QK222 had 
a significantly greater percentage of C1 (67.8 ± 11.8%, 
n = 6) relative to wild type (p = 0.02 Fig.  3b). The mean 
percentage of C1 in two goats homozygous for  K222 (i.e., 
 II142–HH143–NN146–KK222; 60.9 ± 16.1%) was similar 
to that of  NN146–QK222 goats. Since we showed that the 
presence of the  S146 allele in the  NS146–QQ222 genotype 
Table 2 C1 percentage of total  PrPC by PRNP genotype in goats
a II142–HH143–NN146–QQ222 is wild type caprine PRNP
* Mean percent C1 of total  PrPC that is significantly different from wild type 





Mean C1% of total  PrPC 
(± standard deviation)
All goats 50 49.7 ± 13.5
Genotype
 II–HH–NN–QQa 22 46.9 ± 9.3
 IM–HH–NN–QQ 3 41.9 ± 10.4
 II–HR–NN–QQ 5 53.8 ± 6.7
 II–RR–NN–QQ 5 47.2 ± 9.2
 II–HH–NS–QQ 5 33.7 ± 3.2*
 II–HH–NS–QK 2 62.5 ± 32.3
 II–HH–NN–QK 6 67.8 ± 11.8*
 II–HH–NN–KK 2 60.9 ± 16.1
Fig. 3 De‑glycosylation of cellular prion protein reveals full‑length 
 PrPC and fragments C1 and C2. Representative immunoblots of 
cortex homogenate (20 µg total protein) from goats with PRNP 
genotypes that are associated with resistance to classical scrapie. 
Following PNGaseF treatment, SDS‑PAGE, and protein transfer to 
PVDF, immunodetection was performed with BC6 (a) and FH10 
(b); detection of tubulin served as a protein loading control. 
WT =  II142–HH143–NN146–QQ222; NS =  II142–HH143–NS146–QQ222; 
NSQK =  II142–HH143–NS146–QK222; QK =  II142–HH143–NN146–QK222; 
KK =  II142–HH143–NN146–KK222. Sheep (ARR/ARR) homogenate added 
for reference in panel (a)
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reduced the mean level of C1 significantly, it might be 
expected that this was also the case in the two  NS146–
QK222 samples. However, the mean level of C1 observed 
in the  NS146–QK222 samples was almost identical to the 
mean of the  NN146–QK222 samples, but there was a large 
difference between the two  NS146–QK222 samples (~ 45 
points; see Fig. 3a and Additional file 1: Table S1). When 
we performed an immunoblot with F99/97.6.1 to meas-
ure only the PrP  S146–Q222 allele [30, 41], the difference 
between both samples increased by more than 60 points, 
which is the largest difference observed at any single gen-
otype. PRNP haplotypes in both goats were confirmed to 
be mutually exclusive  (N146–K222 and  S146–Q222) as was 
expected based on previous studies [20–22]. Additional 
animals with the  NS146–QK222 allotype are needed to fur-
ther understand the impact of this combination on the 
C1 fragment. Acquiring such samples may present sub-
stantial challenge because of the low prevalence of these 
individual alleles in the UK and USA goat populations 
[20–22] as well as populations from European Union 
member states [29].
We and others have previously demonstrated that 
F99/97.6.1 does not recognize the  K222 allelic variant 
of PrP [30, 41, 42]. Thus, when F99/97.6.1 is applied 
to  QK222 heterozygous samples in immunoblots, only 
the PrP-Q222 allotype (wild type/scrapie susceptible) is 
detected. Unexpectedly, in  NN146–QK222 samples the 
mean for C1 from the single wild type PrP allele was 
68.8 ± 13.4% (n = 6), which was 17.4 points higher than 
in homozygous wild type samples (50.5 ± 10.2%, n = 9) 
measured with F99/97.6.1 alone (see Additional file  1: 
Table S1). This suggests that the putative increased cleav-
age of the  K222 variant is transmitted onto the wild type 
variant, which supports a dimerization model of  PrPC 
[43]. Together, these observations provide evidence for 
an allotype association with the percentage of C1 relative 
to full-length  PrPC in caprine brain.
Relative abundance of  PrPC C1 fragment in goats 
versus sheep
In addition to the polymorphism at codon 240, the wild 
type genotype in goats shares an identical  PrPC sequence 
to the most common ovine allele that is described 
as ARQ in reference to  alanine136,  arginine154 and 
 glutamine171. The average relative abundance of C1 in 
wild type goats (49.7%) is considerably higher than that 
in homozygous ARQ sheep (27.7%, [16]) and approaches 
the value reported for sheep that are homozygous for 
the scrapie resistant ARR genotype (52.6%, [16]). If the 
relative level of C1 is associated with incubation period 
length or susceptibility to scrapie, our data suggest that 
wild type goats may, in general, show longer incubation 
times and reduced susceptibility to scrapie than wild 
type sheep. Although this phenomenon has not been 
addressed directly by experimental challenge studies, we 
have observed longer incubation times in wild type goats 
versus ARQ sheep born to infected dams and raised in 
a similar manner in a persistently infected environment 
(see Additional file 2: Table S2 and Additional file 3: Fig-
ure S1). In addition, it appears that natural scrapie is less 
prevalent in goats than in sheep, unless they are in mixed 
holdings (reviewed in [29]). Furthermore, the relative 
amount of C2 was very low in all goats, mostly below the 
threshold of reliable measurement, which is another fea-
ture of caprine  PrPC processing that was similar to previ-
ous observations in scrapie-resistant ARR sheep [16].
Conclusions
We have shown in a second species, i.e. goat, that an 
association exists between the relative levels of C1 and 
PRNP genotype. We measured the relative abundance 
of the C1 fragment as a percentage of total  PrPC in post-
mortem brain from 50 healthy goats. Thirty-five goats 
were wild type (scrapie susceptible) or had genotypes 
that were associated with extended incubation of classi-
cal scrapie; 16 goats had putative scrapie-resistant geno-
types (at least one  S146 and(or)  K222 allele present). Our 
aim was to investigate an association between the levels 
of the prion protein fragment C1 and PRNP genotype, 
as was previously shown in sheep [16]. Although goats 
of different breeds were included in this study, we could 
not perform an analysis independent of breed due to 
some genotypes being more prevalent in certain breeds 
[20, 21, 29]. Our observations show that resistant  K222 
expressing goats have significantly higher levels of C1 
than wild type goats, which is similar to observations 
in scrapie susceptible  Q171 expressing sheep versus  R171 
sheep that are resistant to classical scrapie. The increased 
percentage of C1 in goats with the  K222 allele may have 
been an anticipated result based on observations in sheep 
but the significantly lower percentage of C1 in goats with 
the  S146 allele was surprising considering that both PRNP 
genotypes are associated with classical scrapie resistance 
in goats. Previously, Eiden and colleagues [44] demon-
strated a lack of  PrPSc-seeded conversion of  PrPC with 
the  S146 and  K222 genotypes. While the increased percent-
age of C1 in goats with the  K222 allele may play a role in 
this phenomenon based on previous observations from 
prion infection studies using transgenic mice or prion 
permissive cell lines [11, 12], additional work is needed 
to understand how a lower percentage of C1 might con-
tribute to the lack of seeded conversion in the presence 
of the  S146 allele. Such experiments that could include an 
assessment of other factors, e.g. breed, are beyond the 
scope of this retrospective observational study. In sum-
mary, we propose that alterations in  PrPC processing may 
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contribute to common mechanisms of differential sus-
ceptibility to protein misfolding and resistance to clas-
sical scrapie disease in goats as has been described in 
sheep.
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